Immune response to influenza vaccination in ESRD patients undergoing hemodialysis vs. hemodiafiltration. 2020

Arkom Nongnuch, and Wattanachai Ngampongpan, and Sirawat Srichatrapimuk, and Artit Wongsa, and Sutheera Thongpraphai, and Chompunuch Boonarkart, and Nutaporn Sanmeema, and Malinee Chittaganpitch, and Prasert Auewarakul, and Boonrat Tassaneetrithep, and Andrew Davenport, and Angsana Phuphuakrat
Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

On-line hemodiafiltration (HDF) clears more azotemic toxins compared to high-flux hemodialysis (HD). The response to vaccination is impaired in dialysis patients. We wished to determine whether the immune responses to influenza vaccine in dialysis patients treated by HDF were stronger than those treated by HD. We conducted a prospective cohort study in chronic dialysis patients during the 2016 and 2017 influenza seasons. All participants received a single standard dose of trivalent influenza vaccine, and we studied the elicited humoral immune response by hemagglutination inhibition test, and cell-mediated immune response by enumeration of lymphocyte cellular markers and proliferation assays. We immunized 60 end-stage renal disease (ESRD) patients: 42 (70%) treated with HD and 18 patients (30%) with HDF. The median (interquartile range) age was 65.0 (55.0-74.5) years. All patients developed seroprotection to at least one influenza vaccine strain at one month post-vaccination, and did not differ between groups. By logistic regression, age was the only factor independently associated with seroconversion to all vaccine strains (odds ratio 0.89, 95% confidence interval 0.80-0.98; p = 0.022). Seroprotection to all vaccine strains was sustained for longer in patients treated with HDF, and the results remained the same after age adjustment. For cellular immune response, patients who seroconverted to all vaccine strains had higher CD38+ T cell subpopulations pre-vaccination. Patients treated by HDF had higher lymphocyte proliferation to circulating influenza A strains. Seroconversion to all influenza vaccine strains was associated with age. Patients treated with HDF demonstrated seroprotection was sustained for longer compared to those treated by HD and greater lymphocyte proliferation to circulating influenza A strains. These encouraging results for HDF require confirmation in a larger dialysis population. ClinicalTrial.gov, NCT04122222.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006385 Hemagglutination Inhibition Tests Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses

Related Publications

Arkom Nongnuch, and Wattanachai Ngampongpan, and Sirawat Srichatrapimuk, and Artit Wongsa, and Sutheera Thongpraphai, and Chompunuch Boonarkart, and Nutaporn Sanmeema, and Malinee Chittaganpitch, and Prasert Auewarakul, and Boonrat Tassaneetrithep, and Andrew Davenport, and Angsana Phuphuakrat
March 2016, Acta medica Iranica,
Arkom Nongnuch, and Wattanachai Ngampongpan, and Sirawat Srichatrapimuk, and Artit Wongsa, and Sutheera Thongpraphai, and Chompunuch Boonarkart, and Nutaporn Sanmeema, and Malinee Chittaganpitch, and Prasert Auewarakul, and Boonrat Tassaneetrithep, and Andrew Davenport, and Angsana Phuphuakrat
January 1989, Atencion primaria,
Arkom Nongnuch, and Wattanachai Ngampongpan, and Sirawat Srichatrapimuk, and Artit Wongsa, and Sutheera Thongpraphai, and Chompunuch Boonarkart, and Nutaporn Sanmeema, and Malinee Chittaganpitch, and Prasert Auewarakul, and Boonrat Tassaneetrithep, and Andrew Davenport, and Angsana Phuphuakrat
January 1994, Lancet (London, England),
Arkom Nongnuch, and Wattanachai Ngampongpan, and Sirawat Srichatrapimuk, and Artit Wongsa, and Sutheera Thongpraphai, and Chompunuch Boonarkart, and Nutaporn Sanmeema, and Malinee Chittaganpitch, and Prasert Auewarakul, and Boonrat Tassaneetrithep, and Andrew Davenport, and Angsana Phuphuakrat
December 1986, Diabetologia,
Arkom Nongnuch, and Wattanachai Ngampongpan, and Sirawat Srichatrapimuk, and Artit Wongsa, and Sutheera Thongpraphai, and Chompunuch Boonarkart, and Nutaporn Sanmeema, and Malinee Chittaganpitch, and Prasert Auewarakul, and Boonrat Tassaneetrithep, and Andrew Davenport, and Angsana Phuphuakrat
January 2014, Central European journal of urology,
Arkom Nongnuch, and Wattanachai Ngampongpan, and Sirawat Srichatrapimuk, and Artit Wongsa, and Sutheera Thongpraphai, and Chompunuch Boonarkart, and Nutaporn Sanmeema, and Malinee Chittaganpitch, and Prasert Auewarakul, and Boonrat Tassaneetrithep, and Andrew Davenport, and Angsana Phuphuakrat
July 2010, Renal failure,
Arkom Nongnuch, and Wattanachai Ngampongpan, and Sirawat Srichatrapimuk, and Artit Wongsa, and Sutheera Thongpraphai, and Chompunuch Boonarkart, and Nutaporn Sanmeema, and Malinee Chittaganpitch, and Prasert Auewarakul, and Boonrat Tassaneetrithep, and Andrew Davenport, and Angsana Phuphuakrat
March 1998, Minerva urologica e nefrologica = The Italian journal of urology and nephrology,
Arkom Nongnuch, and Wattanachai Ngampongpan, and Sirawat Srichatrapimuk, and Artit Wongsa, and Sutheera Thongpraphai, and Chompunuch Boonarkart, and Nutaporn Sanmeema, and Malinee Chittaganpitch, and Prasert Auewarakul, and Boonrat Tassaneetrithep, and Andrew Davenport, and Angsana Phuphuakrat
October 1993, Lancet (London, England),
Arkom Nongnuch, and Wattanachai Ngampongpan, and Sirawat Srichatrapimuk, and Artit Wongsa, and Sutheera Thongpraphai, and Chompunuch Boonarkart, and Nutaporn Sanmeema, and Malinee Chittaganpitch, and Prasert Auewarakul, and Boonrat Tassaneetrithep, and Andrew Davenport, and Angsana Phuphuakrat
December 1993, Lancet (London, England),
Arkom Nongnuch, and Wattanachai Ngampongpan, and Sirawat Srichatrapimuk, and Artit Wongsa, and Sutheera Thongpraphai, and Chompunuch Boonarkart, and Nutaporn Sanmeema, and Malinee Chittaganpitch, and Prasert Auewarakul, and Boonrat Tassaneetrithep, and Andrew Davenport, and Angsana Phuphuakrat
January 1981, The Kurume medical journal,
Copied contents to your clipboard!